Senard J M, Montastruc J L
Laboratoire de Pharmacologie Médicale et Clinique, INSERM U317, Faculté de Médecine, Toulouse, France.
Fundam Clin Pharmacol. 1996;10(3):225-33. doi: 10.1111/j.1472-8206.1996.tb00301.x.
This review focuses on the actual limits of the clinical pharmacology of drugs used for the treatment of orthostatic hypotension. The evidences for heterogeneity of the pathophysiological mechanisms of primary orthostatic hypotension and autonomic failure are discussed. The available data on the efficacy of some drugs used in orthostatic hypotension are also discussed.
本综述聚焦于用于治疗直立性低血压的药物临床药理学的实际局限。讨论了原发性直立性低血压和自主神经功能衰竭病理生理机制异质性的证据。还讨论了一些用于直立性低血压的药物疗效的现有数据。